Filing Flows › Health Catalyst (HCAT) › Technology revenue
Health Catalyst (HCAT) Technology revenue by quarter
Health Catalyst's Technology revenue was $40.7M in Q3 2026 (third quarter 2026), -17% from Q2 2026. Over the last 7 quarters it ranged from $40.7M (Q3 2026) to $52.9M (Q2 2025).
| Quarter | Technology revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $40.7M | -17% | -22% |
| Q2 2026 | $48.8M | -1% | -8% |
| Q1 2026 | $49.5M | -5% | -4% |
| Q4 2025 | $51.9M | -0.4% | — |
| Q3 2025 | $52.1M | -2% | — |
| Q2 2025 | $52.9M | +3% | — |
| Q1 2025 | $51.5M | — | — |
Q3 2026 at a glance
Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%, net earnings $40.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Health Catalyst's Technology revenue?
Health Catalyst's Technology revenue was $40.7M in Q3 2026 (third quarter 2026), -17% from Q2 2026.
How has Health Catalyst's Technology revenue changed?
Over the last 7 quarters it ranged from $40.7M (Q3 2026) to $52.9M (Q2 2025).